Afton Vechery is the Co-Founder of Modern Fertility and served as its CEO. Modern Fertility is a reproductive health company focused on making personalized fertility information more accessible. The company created a category for proactive fertility providing at-home tests and digital tools for women earlier in life, available online and at major retailers. For its first flagship product, Modern Fertility validated that blood tests done in an infertility clinic could be done from home and published their findings in ACOG’s Green Journal. The company built a digital experience that allowed customers to understand their fertility hormones, built one of the leading digital communities for people with ovaries, and expanded their product portfolio to serve women across their reproductive careers. Modern Fertility continues to publish in top tier journals and develop fertility diagnostics utilizing its largest consented database of fertile women. Prior to Modern Fertility, Vechery led strategy and operations at various healthtech startups and most recently led consumer product at 23andMe. Vechery has been named to Fortune’s 40 Under 40 list, Inc.’s Female Founders of 2022 list, Inc.’s 30 Under 30 list and Forbes’ 30 Under 30 list. Modern Fertility was named Fast Company’s #1 Most Innovative Healthcare Company in the world and one of CNBC’s Most Promising Startups to Watch.
In 2021, Vechery sold Modern Fertility to Ro for $225M where she joined as President of Women’s Health. In 2022, Afton transitioned from an operating to advisory role at Ro and is now investing and advising start-ups before she starts her next venture.
Vechery is an alumna of the 2007 Science Talent Search and 2005 International Science and Engineering Fair. She started her first company out of her 2005 ISEF project, which started her entrepreneurial journey.
She joined the Society’s Board of Trustees in 2022.